Salerno Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SALERNO PHARMS, and what generic alternatives to SALERNO PHARMS drugs are available?
SALERNO PHARMS has one approved drug.
There are two US patents protecting SALERNO PHARMS drugs.
There are eight patent family members on SALERNO PHARMS drugs in twelve countries and five supplementary protection certificates in five countries.
Summary for Salerno Pharms
| International Patents: | 8 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Salerno Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salerno Pharms | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-002 | Apr 21, 2016 | RX | Yes | Yes | 10,300,041 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Salerno Pharms | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-001 | Apr 21, 2016 | RX | Yes | No | 9,597,289 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Salerno Pharms | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-002 | Apr 21, 2016 | RX | Yes | Yes | 9,597,289 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Salerno Pharms | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-001 | Apr 21, 2016 | RX | Yes | No | 10,300,041 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Salerno Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Cyprus | 1112917 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 2007125339 | ⤷ Subscribe |
| Denmark | 2018153 | ⤷ Subscribe |
| Austria | E552825 | ⤷ Subscribe |
| Japan | 2009534459 | ⤷ Subscribe |
| Slovenia | 2018153 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Salerno Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0720599 | C300172 | Netherlands | ⤷ Subscribe | PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN SIMVASTATINE; NAT. REGISTRATION NO/DATE: RVG 30927RVG 30928RVG 30929RVG 30930 2004221122; FIRST REGISTRATION: 58874.00.0058874.01.0058874.02.0058874.03.0058878.00.0058878.01.0058878.02.0058878.03.0058866.00.0058866.01.0058866.02.0058866.03.0058870.00.0058870.01.0058870.02.0058870.03.00 2004020402 |
| 0720599 | 122004000026 | Germany | ⤷ Subscribe | PRODUCT NAME: EZETIMIB ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON IN KOMBINATION MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 58866.00.00 58866.01.00 58866.02.00 58866.03.00 58870.00.00 58870.01.00 58870.02.00 58870.03.00 58874.00.00 58874.01.00 58874.02.00 58874.03.00 58878.00.00 58878.01.00 58878.02.00 58878.03.00 20040402 FIRST REGISTRATION: DE 58866.00.00 - 58866.03.00 58870.00.00 - 58870.03.00 58874.00.00 - 58874.03.00 58878.00.00 - 58878.03.00 20040402 |
| 0720599 | SPC/GB05/010 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: EZETIMIBE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN COMBINATION WITH SIMVASTATIN; REGISTERED: DE 58874.00.00 20040402; DE 58874.01.00 20040402; DE 58874.02.00 20040402; DE 58874.03.00 20040402; DE 58878.00.00 20040402; DE 58878.01.00 20040402; DE 58878.02.00 20040402; DE 58878.03.00 20040402; DE 58866.00.00 20040402; DE 58866.01.00 20040402; DE 58866.02.00 20040402; DE 58866.03.00 20040402; DE 58870.00.00 20040402; DE 58870.01.00 20040402; DE 58870.02.00 20040402; DE 58870.03.00 20040402; UK PL 19945/0003 20041118; UK PL 19945/0004 20041118; UK PL 19945/0005 20041118; UK PL 19945/0006 20041118; UK PL 19945/0007 20041118; UK PL 19945/0008 20041118; UK PL 19945/0009 200411 |
| 0720599 | 26/2005 | Austria | ⤷ Subscribe | PRODUCT NAME: EZETIMIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON KOMBINIERT MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 1-25673 - 1-25676 20041228; FIRST REGISTRATION: DE 58874.00.00 - 58874.03.00; 58878.00.00 - 20040402 |
| 0720599 | 05C0040 | France | ⤷ Subscribe | PRODUCT NAME: EZETIMIBE; SIMVASTATINE; NAT. REGISTRATION NO/DATE: NL 31849 20050728; FIRST REGISTRATION: DE - 58 878 00 00 20040402 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
